Related Experiment Video
Updated: May 5, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Screening for Hepatitis C Virus Infection in Adolescents and Adults: US Preventive Services Task Force Recommendation
, Douglas K Owens1,2, Karina W Davidson3
1Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
Insights
Hepatitis C virus (HCV) screening is recommended for adults aged 18 to 79. This screening offers substantial benefits for public health by detecting this common blood-borne pathogen.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- Hepatitis C virus (HCV) is a significant public health concern in the US, being the most common chronic blood-borne pathogen.
- HCV infection leads to chronic liver disease and is associated with a high mortality rate, exceeding that of many other infectious diseases combined.
- Recent years have seen a 3.8-fold increase in acute HCV infections, primarily due to rising injection drug use and enhanced surveillance.
Purpose of the Study:
- To provide an updated evidence-based recommendation on screening for Hepatitis C virus (HCV) infection.
- The review focused on screening adolescents and adults to inform the USPSTF's 2013 recommendation.
Main Methods:
- A comprehensive review of existing evidence on HCV screening was commissioned by the USPSTF.
- The study focused on the efficacy and benefits of screening in the general adult population.
Main Results:
- Screening for HCV infection in adults aged 18 to 79 years demonstrates a substantial net benefit.
- The USPSTF's evidence assessment concluded with moderate certainty regarding the benefits of screening.
Conclusions:
- The USPSTF recommends HCV infection screening for all adults aged 18 to 79 years.
- This recommendation is classified as a 'B recommendation', indicating a high degree of certainty regarding the benefits.
Importance:
Hepatitis C virus (HCV) is the most common chronic blood-borne pathogen in the US and a leading cause of complications from chronic liver disease. HCV is associated with more deaths than the top 60 other reportable infectious diseases combined, including HIV. Cases of acute HCV infection have increased approximately 3.8-fold over the last decade because of increasing injection drug use and improved surveillance.
Objective:
To update its 2013 recommendation, the USPSTF commissioned a review of the evidence on screening for HCV infection in adolescents and adults.
Population:
This recommendation applies to all asymptomatic adults aged 18 to 79 years without known liver disease.
Evidence Assessment:
The USPSTF concludes with moderate certainty that screening for HCV infection in adults aged 18 to 79 years has substantial net benefit.
Recommendation:
The USPSTF recommends screening for HCV infection in adults aged 18 to 79 years. (B recommendation).
More Related Videos
06:46A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Preventive Healthcare Services
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Standard Precaution
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
Sexually Transmitted Infections
Hepatitis
Viral Hepatitis I: Introduction